•Biopharma focused investment banker specializing in strategic transactions and capital advisory services
+ •Lead execution and oversee analysts' deliverables and analyses, ensuring accuracy and strategic alignment
+ •Lead and manage discussions with target counter parties to drive deals to close
+ •Lead strategy engagements across a variety of project types and deliver comprehensive findings and actionable recommendations
+ •Collaborate with client C-suite and management teams to create impactful marketing materials
+ •Perform in-depth quantitative financial analyses, including comparable companies, precedent transactions, and discounted cash flow analyses to support deal negotiations
+
•Rapidly promoted within 6 months in recognition of exceptional project quality improvement and surpassing client expectations, earning the Company Value Award
+ •Executed commercial assessments and developed revenue forecast models to evaluate the commercial potential of novel products for large pharma clients
+ •Evaluated product profiles via primary research with KOLs, clinicians, and payers to inform future clinical trial designs, launch scenarios, and R&D investments
+ •Facilitated workshops with client teams (on-site and virtual) to disseminate research findings and foster constructive discussions amongst key stakeholders to shape strategy and identify growth opportunities
+
•Received Company Impact award for demonstrating curiosity and resilience, and exceeding client expectations
+ •Conducted in-depth analysis of competitor data from over ten major medical conferences to inform client strategy
+ •Generated SWOT analyses and determined competitive threat ratings to pharma companies, marketed drugs, and pipeline assets by analyzing clinical and preclinical data, salesforce readiness, and market access
+
Univeristy Anon. Bachelor of Science
+ +